The invention is directed to indole and indoline cyclopropyl amidederivatives of Formula I as EP4 receptor antagonists useful for the treatmentof EP4mediated diseases or conditions, such as acute and chronic pain,osteoarthritis, rheumatoidarthritis and cancer. Pharmaceutical compositions and methods of use are alsoincluded.(see formula I)